META Pharmaceuticals
Latest round
- Series A
Last raised
- Feb 2025
Total raised
- Undisclosed
Investors
- 5
About META Pharmaceuticals
Founded in 2021, and based in Shenzhen, China, META Pharmaceuticals Inc. is a biotech company that focuses on the development of small molecule innovative drugs based on immunometabolism targets. Ke Xu, the company's co-founder and CEO, worked as a consultant at PreScouter Inc. and provided consulting services to well-known biotech companies Taconic and Tesaro.S. research hospitals, Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center. The company's main products include Meta-01 inhibitors, Meta-02 inhibitors and Meta-03 inhibitors, etc. Meta-01 inhibitors are used in multiple sclerosis, systemic lupus erythematosus, allergic asthma, rheumatoid arthritis, ulcerative colitis and other diseases. Meta-02 inhibitors and Meta-03 inhibitors are used in autoimmune diseases. The company’s revenue is generated by providing drugs for autoimmune and metabolic diseases.
Who invested in META Pharmaceuticals
5 investors across 2 rounds
See all investors in META Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about META Pharmaceuticals
Who invested in META Pharmaceuticals?
META Pharmaceuticals has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has META Pharmaceuticals raised?
META Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did META Pharmaceuticals last raise money?
META Pharmaceuticals's most recent round on record is a Series A, in Feb 2025.
What does META Pharmaceuticals do?
Founded in 2021, and based in Shenzhen, China, META Pharmaceuticals Inc.
Where is META Pharmaceuticals headquartered?
META Pharmaceuticals is headquartered in Shenzhen, China.
Which VCs invest in companies like META Pharmaceuticals?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at META Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like META Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.